Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gsk Plc ADR
(NY:
GSK
)
44.15
+0.70 (+1.61%)
Official Closing Price
Updated: 7:00 PM EDT, May 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gsk Plc ADR
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
28
29
Next >
Pfizer's Pentavalent Meningococcal Vaccine Candidate Shows Efficacy In Adolescents
September 15, 2022
Via
Benzinga
AnaptysBio Sells Royalty Interest In Cancer Drug For $45M
September 12, 2022
Via
Benzinga
September 2022 Stock Considerations
September 08, 2022
Let’s take a look at my September stock considerations which are similar to recent considerations from one to four months ago.
Via
Talk Markets
SpringWorks Shares Pop After Expanded Multiple Myeloma Pact With GSK
September 07, 2022
Via
Benzinga
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
September 06, 2022
Via
Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
Via
Benzinga
GSK's Rare Blood Cancer Candidate Goes Under FDA Review
August 17, 2022
Via
Benzinga
One Suit Down Out Of 3,000 Zantac Related Lawsuits, Says GSK
August 17, 2022
Via
Benzinga
Why IDEAYA Biosciences Shares Plunging Today
August 15, 2022
Via
Benzinga
Novartis Appoints Merck Executive As Research Head
September 01, 2022
Via
Benzinga
With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report
August 30, 2022
Via
Benzinga
IDEAYA Achieves First Milestone In GSK Pact For Pol Theta Helicase Inhibitor Candidate
August 29, 2022
Via
Benzinga
Fighting Omicron: This Covid Vaccine Candidate Is Going After The Dangerous Mutation
August 18, 2022
Via
Benzinga
Recent Stock Purchase August 2022
August 18, 2022
I just continue to have a long-term outlook, continue to invest, diversify my portfolio even more and just hold on.
Via
Talk Markets
Sanofi's Run Of Bad Luck Continues As Pharma Giant Tosses Out A Cancer Drug
August 17, 2022
Shares extended deep losses following a Zantac-inspired downturn last week.
Via
Investor's Business Daily
GSK Confirms Rotavirus Vaccine Shortage, Hits Four African Countries: Report
August 10, 2022
Via
Benzinga
Vir Biotech Shuns FDA Submission Plans For GSK-Partnered COVID-19 Treatment
August 10, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 18, 2022
During Thursday's trading, 62 companies set new 52-week lows.
Via
Benzinga
AstraZeneca Slaps Lawsuit Against Former Employee As He Moves To Close Rival: Report
August 17, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
August 15, 2022
On Monday, 31 companies hit new 52-week lows.
Via
Benzinga
Landmark Drug Pricing Reform Bill Passes Congress House
August 15, 2022
The U.S. House of Representatives voted 220-207 to pass new, wide-ranging legislation allowing Medicare drug price negotiations for the first time and capping seniors’ drug expenses to $2,000 per year...
Via
Benzinga
Do I Need to Get A Polio Vaccine? New York Sewer Discovery Triggers Fears About Paralysis-Inducing Virus
August 12, 2022
New York officials have detected polio in the city's wastewater, suggesting the virus has been circulating in the local area.
Via
Benzinga
Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke
August 11, 2022
Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 11, 2022
On Thursday, 22 companies reached new 52-week lows.
Via
Benzinga
GSK, PFE, SNY Stocks Fall on Zantac Litigation
August 11, 2022
You may think safety concerns about Zantac from 2019 are old news now, but GSK stock traders and others are worried about the repercussions.
Via
InvestorPlace
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
August 11, 2022
These companies are at the center of lawsuits claiming Zantac causes cancer.
Via
Investor's Business Daily
Sonos, Bumble And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
August 11, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
August 10, 2022
During Wednesday, 52 stocks hit new 52-week lows.
Via
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.